Aug 31, 2026 08:32AM
Aug 12, 2026 05:23PM
Jun 10, 2026 05:19AM
May 14, 2026 02:53PM
May 13, 2026 05:15PM
Mar 24, 2026 04:15AM
Mar 19, 2026 03:25PM Oppenheimer on Acrivon Therapeutics Inc (ACRV): 'all-comer' approach comes with risks, but necessary
Mar 19, 2026 07:55AM
Mar 2, 2026 03:39PM
Jan 23, 2026 08:13AM
Jan 9, 2026 08:06AM
Jan 8, 2026 07:32AM
Nov 17, 2025 04:27AM
Nov 13, 2025 06:46PM Acrivon Therapeutics, Inc. (ACRV) Tops Q3 EPS by 69c
Oct 22, 2025 04:27PM
Sep 17, 2025 04:08AM
Aug 15, 2025 05:53AM
Aug 13, 2025 06:10PM
May 30, 2025 05:01AM
May 15, 2025 05:41PM
May 15, 2025 07:26AM Cantor Fitzgerald Reiterates Overweight Rating on Acrivon Therapeutics Inc (ACRV)
May 5, 2025 07:06AM
Apr 7, 2025 04:05PM
Mar 28, 2025 06:45AM
Mar 26, 2025 06:47AM
Mar 26, 2025 06:44AM
Mar 26, 2025 04:05AM
Mar 24, 2025 05:41AM Citizens JMP Reiterates Market Outperform Rating on Acrivon Therapeutics Inc (ACRV)
Feb 5, 2025 08:00AM
Jan 31, 2025 06:04AM
Nov 14, 2024 07:53AM
Nov 13, 2024 05:23PM
Oct 11, 2024 08:03AM
Sep 16, 2024 08:42AM
Sep 16, 2024 07:50AM Piper Sandler Reiterates Overweight Rating on Acrivon Therapeutics Inc (ACRV)
Sep 16, 2024 07:14AM
Sep 16, 2024 06:46AM
Aug 14, 2024 10:04AM
Aug 13, 2024 10:17AM
Aug 13, 2024 10:17AM

456,289 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All